GlaxoSmithKline, the world’s second largest pharmaceuticals company, is probably the most important private-sector contributor to science in the UK and is a significant contributor to global developments in healthcare. But it is no longer seen as the great British success it once was.
For this week's Leading Questions, GSK's new chief executive Andrew Witty, in his first major interview, tells the BBC's Business Editor Robert Peston how he intends to win back the confidence both of investors and of customers.
Bookmark with:
What are these?
E-mail this to a friend